載入...
Antiangiogenic therapies in urogenital malignancies: Fiction or fact?
The use of antiangiogenic agents in cancer therapy has become an attractive target in oncological research. However, concerning the uro-oncological field, current guidelines only recommend the use of antiangiogenic agents in metastatic renal cell cancer. Yet in recent years, several approaches for s...
Na minha lista:
| 發表在: | Memo |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Vienna
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5725505/ https://ncbi.nlm.nih.gov/pubmed/29250197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-017-0375-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|